Interest of transjugular liver biopsy in adult patients with haemophilia or other congenital bleeding disorders infected with hepatitis C virus

British Journal of Haematology

Volumn 125, Issue 6, 2004, Pages 769-776

  Stieltjes, Natalie ^a   Ounnoughene, Nadra ^a   Sava, Emilie ^a   Paugy, Patricia ^a   Roussel Robert, Valérie ^a   Rosenberg, Arielle R ^a   Terris, Benoit ^a   Salmon Céron, Dominique ^a   Sogni, Philippe ^a  

^a Cochin S Vincent de Paul Hospital ^*  (France)

Author keywords

Chronic hepatitis C; Congenital bleeding disorder; Haemophilia; Transjugular liver biopsy

Indexed keywords

ADULT; AGED; ARTICLE; BLEEDING; CONTROLLED STUDY; FEMALE; FIBROSIS; GENOTYPE; HEMOPHILIA; HEMOPHILIA A; HEMOPHILIA B; HEPATITIS C VIRUS; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LIVER BIOPSY; LIVER FAILURE; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; BIOPSY; COSTS AND COST ANALYSIS; HEMOPHILIA A; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; JUGULAR VEINS; LIVER; MIDDLE AGED;

EID: 3042640694     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2004.04968.x     Document Type: Article

References (53)

1. Afdhal, N. (2003) Diagnosing fibrosis in hepatitis C: is the pendulum swinging from biopsy to blood tests? Hepatology, 37, 972-974.
2. Agence Nationale d'Accreditation et d'Evaluation en Sante (2002) Consensus conference. Treatment of hepatitis C. Gastroenterologie Clinique et Biologique, 26, B303-B320.
3. Ahmed, M., Mutimer, D.J., Elias, E., Linin, J., Garrido, M., Hubscher, S., Jarvis, L., Simmonds, P. & Wilde, J.T.D. (1996) A combined management protocol for patients with coagulation disorders infected with hepatitis C virus. British Journal of Haematology, 1996, 383-388.
4. Aledort, L.M., Levine, P.H., Hilgartner, M., Blatt, P., Spero, J.A., Goldberg, J.D., Bianchi, L., Desmet, V., Scheuer, P., Popper, H. & Berk, P.D. (1985) A study of liver biopsies and liver disease among hemophiliacs. Blood, 66, 367-372.
5. Bedossa, P. & Poynard, T. (1996) An algorithm for the grading activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology, 24, 289-293.
6. Benhamou, Y., Di Martino, V., Bochet, M., Colombet, G., Thibault, V., Liou, A., Katlama, C. & Poynard, T. (2001) Factors affecting liver fibrosis in human immunodeficiency virus- and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy. Hepatology, 34, 283-287.
7. Beurton, I., Bertrand, M.A., Bresson-Hadni, S., Parquet-Gernez, A., Goudemand, J., Paris, J.C., Cales, P., Briquel, M.E., Gaucher, P., Cortey, M.L., Trepo, C., Miguet, J.P. & Cahn, J.Y. (2001) Interferon alpha therapy in haemophilic patients with chronic hepatitis C: a French multicentre pilot study of 58 patients. European Journal of Gastroenterology and Hepatology, 13, 859-864.
8. Brettler, D., Alter, H.J., Dienstag, J.L., Forsberg, A.D. & Levine, P.H. (1990) Prevalence of hepatitis C virus antibody in a cohort of hemophilia patients. Blood, 76, 254-256.
9. Cadranel, J.P., Rufat, P. & Degos, F. (2000) Practices of liver biopsy in France: results of a prospective nationwide survey. Hepatology, 32, 477-481.
10. DiMichele, D., Mirani, G., Wilfredo-Canchis, P., Trost, D.W. & Talal, A.H. (2003) Transjugular liver biopsy is safe and diagnostic for patients with congenital bleeding disorders and hepatitis C infection. Haemophilia, 9, 613-618.
11. Donahue, J., Munoz, A., Ness, P.M., Brown, D.E., Yawn, D.H., McAllister, H.A., Reitz, B.A. & Nelson, K.E. (1992) The declining risk of post-transfusion hepatitis C virus infection. New England Journal of Medicine, 327, 369-373.
12. Forns, X., Ampurdanes, S., Llovet, J.M., Aponte, J., Quinto, L., Martinez-Bauer, E. & Bruguera, M. (2002) Identification of chronic hepatitis C without hepatic fibrosis by a simple predictive model. Hepatology, 36, 986-992.
13. Fried, M., Shiffman, M.L., Reddy, K.R., Smith, C., Marinos, G., Gonçales, F.L., Häussiger, D., Diago, M., Carosi, G., Dhumeaux, D., Craxi, A., Lin, A., Hoffman, J. & Yu, J. (2002) PEGinterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. New England Journal of Medicine, 347, 975-982.
14. Froehlich, F., Lamy, O., Fried, M. & Gonvers, J.J. (1993) Practice and complications of liver biopsy results of a nation-wide survey in Switzerland. Digestive Diseases and Sciences, 38, 1480-1484.
15. Garson, J., Tuke, P.W., Makris, M., Briggs, M., Machin, S.J., Preston, F.E. & Tedder, R.S. (1990) Demonstration of viraemia patterns in haemophiliacs treated with hepatitis-C-virus-contaminated factor VIII concentrates. Lancet, 336, 1022-1025.
16. Ghany, M., Leissinger, C., Lagier, R., Sanchez-Pescador, R. & Lok, A.S. (1996) Effect of human immunodeficiency virus infection on hepatitis C virus infection in hemophiliacs. Digestive Diseases and Sciences, 41, 1265-1272.
17. Gupta, R., Druy, E.M. & Kessler, C.M. (1997) Safety and potential usefulness of liver biopsy in HIV seropositive haemophiliacs employing a transjugular venous approach. Haemophilia, 3, 201-204.
18. Hanley, J.P., Jarvis, L.M., Andrews, J., Dennis, R., Lee, R., Simmonds, P., Piris, J., Hayes, P. & Ludlam, C.A. (1996) Investigation of chronic hepatitis C infection in individuals with haemophilia: assessment of invasive and non-invasive methods. Mount Sinai Journal of Medicine, 63, 225-235.
19. Imbert-Bismut, F., Ratziu, V., Pieroni, L., Charlotte, F., Benhamou, Y. & Poynard, T. (2001) Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet, 357, 1069-1075.
20. Lebrec, D. (1996) Various approaches to obtaining liver tissue. Choosing the biopsy technique. Journal of Hepatology, 25, S20-S24.
21. Lebrec, D., Goldfarb, G., Degott, C., Rueff, B. & Benhamou, J.P. (1982) Transvenous liver biopsy. An experience based on 1000 hepatic tissue samplings with this procedure. Gastroenterology, 83, 338-340.
22. Lee, C.A. (1997) Investigation of chronic hepatitis C infection in individuals with haemophilia. British Journal of Haematology, 96, 425-426.
23. Lesens, O., Deschenes, M., Steben, M., Belanger, G. & Tsoukas, C.M. (1999) Hepatitis C virus is related to progressive liver disease in human immunodeficiency virus-positive hemophiliacs and should be treated as an opportunistic infection. Journal of Infectious Diseases, 179, 1254-1258.
24. Lethagen, S., Widell, A., Berntorp, E., Verbaan, H. & Lindgren, S. (2001) Clinical spectrum of hepatitis C-related liver disease and response to treatment with interferon and ribavirin in haemophilia or von Willebrand disease. British Journal of Haematology, 113, 87-93.
25. Makris, M., Preston, F.E., Triger, D.R., Underwood, J.C.E., Choo, Q., Kuo, G. & Houghton, M. (1990) Hepatitis C antibody and chronic liver disease in haemophilia. Lancet, 325, 1117.
26. Makris, M., Preston, F.E., Rosendaal, F.R., Underwood, J.C.E., Rice, K.M. & Triger, D.R. (1996) The natural history of chronic hepatitis C in haemophiliacs. British Journal of Haematology, 94, 746-752.
27. Makris, M., Baglin, T., Dusheiko, G., Giangrande, P.L., Lee, C.A., Ludlam, C.A., Preston, F.E., Watson, H.G., Wilde, J.T. & Winter, M. (2001) Guidelines on the diagnosis, management and prevention of hepatitis in haemophilia. Haemophilia, 7, 339-345.
28. Manns, M., McHutchison, J.G., Gordon, S.C., Rustgi, V.K., Shiffman, L., Reindollar, R., Goodmann, Z.D., Koury, K., Ling, M.H. & Albrecht, J.K. (2001) Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet, 358, 958-965.
29. Mariani, G., Di Paolantonio, T., Baklaya, R., Morfini, M. & Mannucci, P.M. (1993) Prospective study of the evaluation of hepatitis C virus infectivity in a high-purity, solvent/detergent-treated factor VIII concentrate: parallel evaluation of other markers for lipid-enveloped and non-lipid-enveloped viruses. The Ad Hoc Study Group of the Fondazione dell'Emofilia. Transfusion, 33, 814-818.
30. McHutchison, J., Gordon, S.C., Schiff, E.R., Shiffman, M.L., Lee, W.M., Rustgi, V.K., Goodmann, Z.D., Ling, M.H., Cort, S. & Albrecht, J.K. (1998) Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. New England Journal of Medicine, 339, 1485-1492.
31. McMahon, C., Pilkington, R., Shea, E.G., Kelleher, D. & Smith, O.P. (2000) Liver biopsy in Irish hepatitis C-infected patients with inherited bleeding disorders. British Journal of Haematology, 109, 354-359.
32. Mohsen, A., Easterbrook, P.J., Taylor, C., Portmann, B., Kulasegaram, R., Murad, S., Wiselka, M. & Norris, S. (2003) Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients. Gut, 52, 1035-1040.
33. Morfini, M., Mannucci, P.M., Ciavarella, N., Schiavoni, M., Gringeri, A., Ralanelli, D., Di Bona, E., Chistolini, A., Tagliaferri, A. & Rodorigo, G. (1994) Prevalence of infection with the hepatitis C virus among Italian hemophiliacs before and after the introduction of virally inactivated clotting factor concentrates: a retrospective evaluation. Vox Sanguinis, 67, 178-182.
34. Myers, P., Benhamou, Y., Imbert-Bismut, F., Thibault, V., Bochet, M., Charlotte, F., Ratziu, V., Bricaire, F., Katlama, C. & Poynard, T. (2003) Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients. AIDS, 17, 721-723.
35. National Institutes of Health (2002) National Institutes of Health Consensus Development Conference Statement: Management of Hepatitis C 2002. Gastroenterology, 123, 2082-2099.
36. Pessione, F., Degos, F., Marcellin, P., Duchatelle, V., Njapoum, C., Martinot-Peignoux, M., Degott, C., Valla, D., Erlinger, S. & Rueff, B. (1998) Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C. Hepatology, 27, 1717-1722.
37. Pistello, M., Ceccherini-Nelli, L., Cecconi, N., Bendinelli, M. & Panicucci, F. (1991) Hepatitis C virus seroprevalence in Italian haemophiliacs injected with virus-inactivated concentrates: five year follow-up and correlation with antibodies to other viruses. Journal of Medical Virology, 33, 43-46.
38. Poynard, T., Bedossa, P., Opolon, P., OBSVIRC, METAVIR, CLINIVIR & DOSVIRC (1997) Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet, 349, 825-832.
39. Poynard, T., Marcellin, P., Lee, S.S., Niederau, C., Minuk, G.S., Ideo, G., Bain, V., Heathcote, J., Zeuzem, S., Trepo, C. & Albrecht, J.K. (1998) Randomised trial of interferon a2b plus ribavirin for 48 weeks or for 24 weeks versus interferon a2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. Lancet, 352, 1426-1432.
40. Puoti, M., Bonacini, M., Spinetti, A., Putzolu, V., Govindarajan, S., Zaltron, S., Favret, M., Callea, F., Gargiulo, F., Donato, F. & Carosi, G. (2001) Liver fibrosis progression is related to CD4 cell depletion in patients coinfected with hepatitis C virus and human immunodeficiency virus. Journal of Infectious Diseases, 183, 134-137.
41. Ragni, M.V. & Belle, S.H. (2001) Impact of human immunodeficiency virus infection on progression to end-stage liver disease in individuals with hemophilia and hepatitis C virus infection. Journal of Infectious Diseases, 183, 1112-1115.
42. Reichard, O., Norkrans, G., Fryden, A., Braconier, J.H., Sönnerborg, A. & Weiland, O. (1998) Randomised, double-blind, placebo-controlled trial of interferon a2b with and without ribavirin for chronic hepatitis C. Lancet, 351, 83-87.
43. Rumi, M., Santagostino, E., Morfini, M., Gringeri, A., Tagariello, G., Chistolini, A., Pontisso, P., Tagger, A., Colombo, M. & Mannucci, P.M. (1997) A multicenter controlled, randomized, open trial of interferon alpha2b treatment of anti-human immunodeficiency virus-negative hemophilic patients with chronic hepatitis C. Blood, 89, 3529-3533.
44. Santagostino, E., Rumi, M.G., Rivi, M., Colombo, M. & Mannucci, P.M. (2002) Sustained suppression of hepatitis C virus by interferon and ribavirin in hemophilic patients not responding to interferon monotherapy. Blood, 99, 1089-1091.
45. Sauleda, S., Esteban, J.I., Altisent, C., Puig, L., Esteban, R. & Guardia, J. (2000) Treatment with interferon plus ribavirin in anti-HIV negative patients with congenital coagulation disorders and chronic hepatitis C. Thrombosis and Haemostasis, 83, 807-810.
46. Shields, P.L., Mutimer, D., Muir, D., Skidmore, S., Britnell, T., Roberts, A. & Wilde, J.T. (2000) Combined alpha interferon and ribavirin for the treatment of hepatitis C in patients with hereditary bleeding disorders. British Journal of Haematology, 108, 254-258.
47. Telfer, P. (1997) Liver biopsy for haemophilic patients with chronic HCV infection. British Journal of Haematology, 99, 237-241.
48. The French METAVIR Cooperative Study Group (1994) Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology, 20, 15-20.
49. Troisi, C.L., Hollinger, F.B., Hoots, W.K., Contant, C., Gill, J., Ragni, M., Parmley, R., Sexauer, C., Gomperts, E. & Buchanan, G. (1993) A multicenter study of viral hepatitis in a United States hemophilic population. Blood, 81, 412-418.
50. Venkataramani, A., Behling, C., Rond, R., Glass, C. & Lyche, K. (2000) Liver biopsies in adult hemophiliacs with hepatitis C: a United States center's experience. American Journal of Gastroenterology, 95, 2374-2376.
51. Watson, H.G., Ludlam, C.A., Rebus, S., Zhang, L.Q., Peutherer, J.F. & Simmonds, P. (1992) Use of several second generation serological assays to determine the true prevalence of hepatitis C virus infection in haemophiliacs treated with non-virus inactivated factor VIII and IX concentrates. British Journal of Haematology, 80, 514-518.
52. Wiley, T., McCarthy, M., Breidi, L. & Layden, T.J. (1998) Impact of alcohol on the histological and clinical progression of hepatitis C infection. Hepatology, 28, 805-809.
53. Yee, T.T., Griffioen, A., Sabin, C.A., Dusheiko, G. & Lee, C.A. (2000) The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985. Gut, 47, 845-851.